Pivot Park verwelkomt 500-ste werknemer
Met de komst van Noviocell heeft Pivot Park de 500-ste werknemer op de open innovatie campus verwelkomd.
Read more
BioConnection ontvangt een voucher van de Kracht van New Business Oss
Vrijdag 13 januari was een feestelijke dag voor BioConnection. Zij ontvingen een voucher ter waarde van € 20.000 van de Kracht van New Business Oss.
Read more
Synaffix announces key patent covering glycan-conjugated ADC process
Synaffix interviewd by Pharma TV and announces key patent covering glycan-conjugated ADC process granted in the US.
Read more
Back at Pivot Park: Vivenics
Vivenics provides consultancy and software services for data management and data integrity.
Read more
Results from the Phase I/II ACE-CL-001 clinical trial of acalabrutinib
AstraZeneca and Acerta Pharma announce results from the Phase I/II ACE-CL-001 clinical trial of acalabrutinib.
Read more
NTRC’s Oncolines™ profiling is cover story in December issue of Molecular Cancer Therapeutics
An analysis by NTRC of 122 anti-cancer agents is cover story of Molecular Cancer Therapeutics.
Read more
PRIO Pharma launched at BIO Europe
PRIO pharma enables drug development innovations by co-creation.
Read more
New at Pivot Park: Mr. Pepper
“We are the Mr. Pepper company, the first independent distributor of social robotics solutions in the Netherlands.”
Read more